Jane Street’s ProShares Ultra Health Care RXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,502
| Closed | -$364K | – | 10410 |
|
|
2024
Q3 | $364K | Buy |
+6,502
| New | +$354K | ﹤0.01% | 7721 |
|
|
2024
Q2 | – | Sell |
-7,076
| Closed | -$376K | – | 10089 |
|
|
2024
Q1 | $376K | Buy |
+7,076
| New | +$355K | ﹤0.01% | 7184 |
|
|
2022
Q4 | – | Sell |
-18,140
| Closed | -$700K | – | 10011 |
|
|
2022
Q3 | $700K | Sell |
18,140
-2,722
| -13% | -$120K | ﹤0.01% | 6067 |
|
|
2022
Q2 | $910K | Buy |
+20,862
| New | +$959K | ﹤0.01% | 5663 |
|
|
2020
Q2 | – | Sell |
-23,416
| Closed | -$531K | – | 7523 |
|
|
2020
Q1 | $531K | Buy |
+23,416
| New | +$674K | ﹤0.01% | 3570 |
|
|
2019
Q3 | – | Sell |
-38,356
| Closed | -$1.01M | – | 5660 |
|
|
2019
Q2 | $1.01M | Buy |
+38,356
| New | +$951K | ﹤0.01% | 2688 |
|
|
2019
Q1 | – | Sell |
-56,684
| Closed | -$1.29M | – | 5544 |
|
|
2018
Q4 | $1.29M | Sell |
56,684
-30,992
| -35% | -$796K | ﹤0.01% | 2227 |
|
|
2018
Q3 | $2.55M | Buy |
87,676
+20,972
| +31% | +$551K | 0.01% | 1653 |
|
|
2018
Q2 | $1.51M | Sell |
66,704
-21,772
| -25% | -$479K | ﹤0.01% | 2256 |
|
|
2018
Q1 | $1.9M | Buy |
88,476
+57,524
| +186% | +$1.34M | ﹤0.01% | 1917 |
|
|
2017
Q4 | $683K | Sell |
30,952
-11,204
| -27% | -$243K | ﹤0.01% | 2808 |
|
|
2017
Q3 | $901K | Buy |
42,156
+4,260
| +11% | +$87.4K | ﹤0.01% | 2409 |
|
|
2017
Q2 | $758K | Sell |
37,896
-34,884
| -48% | -$643K | ﹤0.01% | 2519 |
|
|
2017
Q1 | $1.28M | Sell |
72,780
-17,076
| -19% | -$287K | 0.01% | 1803 |
|
|
2016
Q4 | $1.35M | Buy |
89,856
+65,432
| +268% | +$992K | 0.01% | 1704 |
|
|
2016
Q3 | $402K | Buy |
24,424
+2,192
| +10% | +$37K | ﹤0.01% | 2997 |
|
|
2016
Q2 | $355K | Sell |
22,232
-13,524
| -38% | -$209K | ﹤0.01% | 3122 |
|
|
2016
Q1 | $511K | Sell |
35,756
-145,984
| -80% | -$2.03M | ﹤0.01% | 2581 |
|
|
2015
Q4 | $3M | Buy |
181,740
+78,464
| +76% | +$1.26M | 0.02% | 769 |
|
|
2015
Q3 | $1.47M | Sell |
103,276
-12,992
| -11% | -$231K | 0.01% | 1254 |
|
|
2015
Q2 | $2.16M | Buy |
116,268
+70,100
| +152% | +$1.28M | 0.01% | 946 |
|
|
2015
Q1 | $816K | Sell |
46,168
-5,952
| -11% | -$100K | 0.01% | 1560 |
|
|
2014
Q4 | $807K | Buy |
+52,120
| New | +$768K | 0.01% | 1171 |
|
|
2014
Q3 | – | Sell |
-247,944
| Closed | -$3.04M | – | 2975 |
|
|
2014
Q2 | $3.04M | Buy |
247,944
+215,120
| +655% | +$2.44M | 0.04% | 389 |
|
|
2014
Q1 | $370K | Buy |
+32,824
| New | +$362K | ﹤0.01% | 1813 |
|
Other funds holding RXL
TFA
CIAS
BCWM
CAS
Jane Street's RXL Position: Q4 2024 in Review
Jane Street sold out of ProShares Ultra Health Care (RXL) in Q4 2024, closing a stake of 6,502 shares — an estimated $364K sold.
Jane Street first reported a position in RXL in Q1 2014 and held it in 25 quarters. The position peaked at $3.04M in Q2 2014. 16 funds tracked by Wall St. Rank hold RXL as of Q4 2024.
- Jane Street reported no remaining ProShares Ultra Health Care position as of Q4 2024 after selling out during the quarter.
- Jane Street sold 6,502 ProShares Ultra Health Care shares in Q4 2024, an estimated $364K.
- Jane Street first reported a position in ProShares Ultra Health Care in Q1 2014 and held it in 25 quarters.
- Jane Street's ProShares Ultra Health Care position peaked at $3.04M in Q2 2014.
- 16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2024.
Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.